LINC00173 facilitates tumor progression by stimulating RAB1B ‐mediated PA2G4 and SDF4 secretion in nasopharyngeal carcinoma
Molecular Oncology · 2023
DOI: 10.1002/1878-0261.13375 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Oncology, 2023. Verfasst von Shi-Wei He und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carci…. Hauptthemen laut MEDLINE: Nasopharyngeal Neoplasms, rab1 GTP-Binding Proteins, RNA, Long Noncoding, RNA-Binding Proteins. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province.
Abstract (Originalsprache)
An increasing number of studies have found that long non‐coding RNA (lncRNA) play important roles in driving the progression of nasopharyngeal carcinoma (NPC). Our microarray screening revealed that expression of the lncRNA long intergenic non‐protein coding RNA 173 ( LINC00173 ) was upregulated in NPC. However, its role and mechanism in NPC have not yet been elucidated. In this study, we demonstrate that high LINC00173 expression indicated a poor prognosis in NPC patients. Knockdown of LINC00173 significantly inhibited NPC cell proliferation, migration and invasion in vitro . Mechanistically, LINC00173 interacted and colocalized with Ras‐related protein Rab‐1B (RAB1B) in the cytoplasm, but the modulation of LINC00173 expression did not affect the expression of RAB1B at either the mRNA or protein levels. Instead, relying on the stimulation of RAB1B, LINC00173 could facilitate the extracellular secretion of proliferation‐associated 2G4 (PA2G4) and stromal cell‐derived factor 4 (SDF4; also known as 45‐kDa calcium‐binding protein) proteins, and knockdown of these proteins could reverse the NPC aggressive phenotype induced by LINC00173 overexpression. Moreover, in vivo LINC00173 ‐knockdown models exhibited a marked slowdown in tumor growth and a significant reduction in lymph node and lung metastases. In summary, LINC00173 serves as a crucial driver for NPC progression, and the LINC00173 –RAB1B–PA2G4/SDF4 axis might provide a potential therapeutic target for NPC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guan…
ORCID-Profile: Na Liu
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
Zitieren
APA
He, S. W., Liang, Y. L., Zhang, Y., Liu, X., Gong, S., Ye, M. L., Huang, S. Y., Tan, X. R., Zhou, S. Q., Zhao, Y., Liu, N., & Li, Y. Q. (2023). LINC00173 facilitates tumor progression by stimulating RAB1B ‐mediated PA2G4 and SDF4 secretion in nasopharyngeal carcinoma. Molecular Oncology. https://doi.org/10.1002/1878-0261.13375
Vancouver
He SW, Liang YL, Zhang Y, Liu X, Gong S, Ye ML, et al. LINC00173 facilitates tumor progression by stimulating RAB1B ‐mediated PA2G4 and SDF4 secretion in nasopharyngeal carcinoma. Molecular Oncology. 2023. doi:10.1002/1878-0261.13375
BibTeX
@article{He2023,
author = {He, Shi-Wei and Liang, Ye-Lin and Zhang, Yuan and Liu, Xu and Gong, Sha and Ye, Ming-Liang and Huang, Sheng-Yan and Tan, Xi-Rong and Zhou, Shi-Qing and Zhao, Yin and Liu, Na and Li, Ying-Qing},
title = {LINC00173 facilitates tumor progression by stimulating RAB1B ‐mediated PA2G4 and SDF4 secretion in nasopharyngeal carcinoma},
journal = {Molecular Oncology},
year = {2023},
doi = {10.1002/1878-0261.13375}
}
EUVIMED